ACTILYSE 50MG INJECTION

ACTILYSE 50MG INJECTION is most effective when administered within the recommended time window and in specific cases of acute ischemic stroke, pulmonary embolism, or acute myocardial infarction. Its use must be carefully evaluated on a case-by-case basis by qualified healthcare professionals.

ACTILYSE 50MG INJECTION is contraindicated in certain conditions, such as active bleeding, recent major surgery, intracranial hemorrhage, known hypersensitivity to it, and other situations with an increased risk of bleeding.

Before administering ACTILYSE 50MG INJECTION, healthcare professionals typically perform brain imaging (CT or MRI) to rule out hemorrhagic stroke, which is a contraindication for this medication use. They may also conduct blood tests to assess coagulation parameters and ensure that the patient meets the necessary criteria for treatment.

There is no specific reversal agent for ACTILYSE 50MG INJECTION. In case of severe bleeding complications, healthcare professionals may use supportive measures, blood products, or other interventions to manage bleeding. Close monitoring and immediate medical attention are essential to address any adverse events promptly.

ACTILYSE 50MG INJECTION is not approved for use in children or adolescents for stroke treatment. Its use in this population is limited to specific cases and requires expert evaluation and consideration of the risks and benefits.

Yes, ACTILYSE 50MG INJECTION can interact with other medications, especially those affecting blood clotting. It is crucial to inform your healthcare professional about all medications, including prescription, over-the-counter, and herbal supplements, before receiving ACTILYSE 50MG INJECTION. They will assess potential interactions and adjust your treatment plan if necessary.

Always consult with a healthcare professional before starting or making any changes to your medication regimen. Tell your doctor if you have a history of bleeding disorders, recent surgery or trauma, gastrointestinal bleeding, or other conditions that may increase bleeding risk. Close monitoring of patients is required throughout treatment to detect any bleeding or adverse reactions promptly. ACTILYSE 50MG INJECTION should be used in a hospital setting with access to emergency facilities, and immediate medical care must be available in case of complications. Pregnancy and breastfeeding women should consult a doctor before starting treatment. Advanced age can increase the risk of bleeding complications with this medication, particularly in patients over 75. The dosage adjustment is required in elderly patients.

The active molecule in ACTILYSE 50MG INJECTION is ALTEPLASE. Alteplase is a thrombolytic agent that helps dissolve blood clots.

ACTILYSE 50MG INJECTION is prescribed to dissolve blood clots that can cause serious conditions such as acute ischemic stroke, pulmonary embolism (a blood clot in the lungs), and acute myocardial infarction (a heart attack).